The New Economics of Functional Nutrition: When Price, Promotion and Consumer Intent Collide

The next battleground in functional nutrition is not demand—it is the ability to price, promote and supply to a consumer changing faster than models can measure. Across the US and Europe, private label is gaining ground: Europe’s private-label share has reached about 40%, while US shoppers are increasingly trading toward store brands. At the same time, GLP-1 adoption is rewriting the basket. PwC estimates 21% of US households included a GLP-1 user by May 2026; BCG found active users intend to spend more on protein, produce and supplements while reducing indulgence. That creates a commercial equation for manufacturers of protein, probiotics and omega-3: demand may be growing, but willingness-to-pay, promotion response, channel mix and retailer bargaining power are moving simultaneously. Tariffs add another layer of margin uncertainty and can make SKUs uneconomic. Capital is following the opportunity—with greater selectivity. S&P Global recorded $5.92 billion of PE food-producer deals through July 2026. CVC agreed to acquire IFF’s Food Ingredients business for about $4.3 billion; Ingredion agreed to acquire Tate & Lyle for $3.6 billion. European alternative-protein companies raised €236 million in H1 2026. The emerging data requirement is commercial: elasticity by SKU and channel, promotion incrementality, private-label substitution, tariff exposure and consumer intent must converge. Apex’s Ingress, Digital Sonar, Apex Consumer Vantage and Apexis connect these signals into one decision layer—helping management and investors see where volume, price, margin and consumer demand are actually moving. Connect: info@apxmetrics.com | Apex Metrics